Sudo Biosciences is a biopharmaceutical company committed to designing and developing novel, best-in-class medicines to transform patients’ lives. Our lead programs target the tyrosine kinase 2 (TYK2) pseudokinase domain. TYK2 is a key mediator in cytokine signaling pathways that have been linked to a broad range of immune-mediated inflammatory conditions.
Company Details
- Employees
- 24
- Address
- 10401 N Meridian St,
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://www.sudobio.com/
- Keywords
- in study management will be instrumental in the successful execution of our programs and studies..
- HQ
- Carmel, Indiana
Sudo Biosciences Questions
Sudo Biosciences's website is https://www.sudobio.com/
Sudo Biosciences's LinkedIn profile is https://www.linkedin.com/company/sudo-biosciences
Sudo Biosciences has
24 employees.
View email and phone details for 24
employees at Sudo Biosciences.
Sudo Biosciences's industry is
Biotechnology Research
Sudo Biosciences's top competitors are
Mbx Biosciences, Inc.,
Morphimmune,
Quralis,
Relmada Therapeutics, Inc,
Delix Therapeutics,
Kimia Therapeutics,
Maplight Therapeutics, Inc.,
Lassen Therapeutics,
Seismic Therapeutic,
Nxera Pharma.
Sudo Biosciences's categories are Biotechnology Research
